Patent

Aker BioMarine acquires IP & equipment from Acasti Pharma Inc.

31-Oct-2023 By Stephen Daniells

Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc.

NutraCast: Less is more: The evolution of high bioavailable natural products

20-Oct-2023 By Danielle Masterson

Since 2003, SourceOne has provided health and wellness solutions to brands around the world. Its focus is on clinically-proven formulations combined with technologically-advanced and patented delivery systems. Jesse Lopez, CEO and Founder of SourceOne...

First creatine for immune support receives research patent

19-Oct-2023 By Asia Sherman

CON-CRĒT by Vireo Systems now holds the patent for research supporting creatine’s ability to help the body fight off coronavirus and influenza A.

NR legal rumbles continue as USPTO board splits recent decisions on patent challenges

23-Aug-2022 By Stephen Daniells

The U.S. Patent & Trademark Office’s Patent Trial and Appeal Board’s (PTAB) recently rejected a challenge by Thorne Research, Inc. against one of the key patents covering nicotinamide riboside, coming a few months after the PTAB ruled in favor of...

StabiCaps the second in Rousselot gelatine portfolio to receive EU patent

10-May-2022 By Will Chu

Darling Ingredients health brand, Rousselot, has secured a European patent for its StabiCaps, a gelatine excipient solution that improves soft gel formulation and stability.

BGG prevails in patent suit filed by vitamin E competitor American River Nutrition

21-Feb-2022 By Hank Schultz

Chinese ingredient supplier BGG World has announced a favorable outcome in a patent infringement lawsuit filed by an American vitamin E competitor.

Judge rules to invalidate two NR patents in win for Elysium Health

24-Sep-2021 By Stephen Daniells

US Judge Colm Connolly, United States District Court for the District of Delaware, has granted the request from Elysium Health to invalidate two Dartmouth College patents licensed by ChromaDex relating to nicotinamide riboside.

NutraCast: Attorney Kevin Bell on 3D technology patents for dietary supplements

20-Aug-2021 By Danielle Masterson

3D printing technology can be applied to pretty much any industry. It's prevalent in aerospace, jewelry and prosthetics. Even dietary supplements can be made this way.

AstaReal builds IP for Astaxanthin to support ‘next-gen’ beneficial gut bacteria

10-May-2021 By Stephen Daniells

The US Patent and Trademark Office has granted a patent covering the use of astaxanthin to boost levels of Akkermansia muciniphila.

ChromaDex, Elysium lock horns over outcome of appeals court decision on nicotinamide riboside patents

21-Apr-2020 By Hank Schultz

Ingredient developer ChromaDex Corp. and former customer Elysium Health have taken sharply differing views of the import of a recent appeals court decision regarding ChromaDex's patents on its nicotinamide riboside ingredient.

DSM lodges patent infringement law suit in China; seeks monetary damages

07-Aug-2018 By Gary Scattergood

DSM is pursuing a patent infringement law suit in China against a competitor for alleged misappropriation of intellectual property related to the production of a key ingredient of Biotin, also known as vitamin B7 or vitamin H.

Allowing matter to lapse dooms patent suit filed over feverfew formulation

23-May-2018 By Hank Schultz

The maker of a dietary supplement focused on migraine relief has prevailed in a patent suit based on a legal doctrine relating to how long a case remains quiescent.

NattoPharma builds patent portfolio for MenaQ7 ingredient

09-Nov-2017 By Hank Schultz

Vitamin K2 supplier NattoPharma ASA has announced three new process patents for its MenaQ7 ingredient in the US, Australia and Israel.

NAI self-affirms GRAS for sustained release CarnoSyn, builds IP

21-Apr-2017

The Generally Recognized as Safe (GRAS) status of Natural Alternatives International’s sustained release beta-alanine (SR CarnoSyn) has been affirmed by a panel of independent experts.

Aker ends ITC case against Olympic, but district court patent infringement suit to continue

20-Apr-2017 By Hank Schultz

Aker BioMarine has pulled the plug on its patent infringement suit that was being pursued before the International Trade Commission.  But the company is still suing a Norwegian competitor and an American distribution partner in district court.

Hi-Tech wins fees in patent case, expands distribution

14-Apr-2017 By Hank Schultz

Controversial sports nutrition brand Hi-Tech Pharmaceuticals continues to make news with the announcement of a victory against a prolific patent enforcement entity and expansion of its distribution footprint.

Aker wins patent fight as Chinese competitor withdraws from US market

31-Jan-2017 By Hank Schultz

Krill oil supplier Aker BioMarine has won an important patent victory as a Chinese competitor has agreed to permanently withdraw its krill oil products from the US market.

Kemin & OmniActive resolve legal differences, begin to form Lutein and Zeaxanthin Trade Organization

12-Dec-2016 By Stephen Daniells

OmniActive Health Technologies, Ltd. and Kemin Industries, Inc. have settled their legal disputes and will cross license ‘use patents’ on lutein, zeaxanthin and their isomers.

Aker, Neptune reach landmark krill oil licensing agreement

04-Oct-2016 By Hank Schultz

The Thirty Years War that reshaped Europe featured myriad twists and turns. The Krill Wars have, too, with the latest being a final, formal burying of the hatchet between the two principal players, Aker BioMarine and Neptune Technologies and Bioressources.

Aker's ITC case against Rimfrost et al. shows that krill wars aren't over yet

28-Sep-2016 By Hank Schultz

The krill wars have resurfaced in a big way with the filing of a patent infringement action before the International Trade Commission by Aker BioMarine against competitor Rimfrost and two of its partners.

NAI settles prolonged beta alanine patent suit against Woodbolt

22-Mar-2016 By Hank Schultz

Natural Alternatives International Inc. has settled one of its longest-standing patent infringement cases on its CarnoSyn beta-alanine ingredient. Defendant Woodbolt Distribution Inc. has agreed to a licensing arrangement in a case that has gone on for...

Aker BioMarine gets two ‘important’ US patents

26-May-2015 By Stephen DANIELLS

The US Patent and Trademark Office has granted krill oil supplier Aker BioMarine two process patents, a development described by the company as ‘important’.

Nutrition 21 announces settlement of patent infringement lawsuit over Chromium Picolinate

04-Mar-2015 By Stephen DANIELLS

Nutrition 21 LLC and JDS Therapeutics LLC have entered into a confidential settlement and license agreement with Schwabe North America and Nature’s Way, thereby ending a patent infringement lawsuit involving the use of chromium picolinate.

Settlement on curcumin patent infringement just tip of the iceberg, Sabinsa says

03-Mar-2015 By Hank Schultz

Botanical ingredients supplier Sabinsa Corporation prides itself on its long list of patents and the history of innovation that represents. The company is making headway in defending that legacy in the curcumin sector with the announcement of the settlement...

Nestlé files patent for kids’ ‘protein balance’

03-Sep-2014 By Anne Bruce

Nestlé has filed for a worldwide patent for a protein balancing product aimed at children aged 5-15.

Neptune and Enzymotec finalize patent settlement and license agreement

28-Apr-2014 By Stephen DANIELLS

The long-running krill oil patent dispute between Canada’s Neptune Technologies & Bioressources and Israel-based Enzymotec Ltd. has come to an end, with the firms signing a final and binding patent infringement settlement and license agreement.

Krill wars redux: Enzymotec ends settlement negotiations with Neptune, ITC case to go forward

02-Apr-2014 By Hank Schultz

In a new phase of a long-standing krill oil patent dispute, Israel-based Enzymotec Ltd. has backed out of a settlement negotiation with Canada’s Neptune Technologies & Bioressources, both companies confirm. Enzymotec said it halted negotiations after...

Patents, like castles, are easier to defend when properly constructed, expert says

03-Mar-2014 By Hank Schultz

Patent enforcement has become more of a hot button issue in the dietary supplement realm for a number of reasons. Companies are gaining a deeper appreciation of how a strong intellectual property portfolio can both add to their bottom line and to the...

Thorne files suit to defend newly-acquired CoQ10 patent

26-Aug-2013

Thorne Research has moved to defend a CoQ10 patent to which it recently acquired exclusive rights and has sued Xymogen, an Orlando, FL-based supplement manufacturer and marketer.

Neptune's European patent on krill oil revoked

10-Apr-2013 By Hank Schultz

The European Patent Office has revoked one of the patents held by krill oil supplier Neptune Technologies & Bioressources.  As has become de rigueur in the IP battle among krill companies, the various players disagree about what the action means.

Neptune gets new US krill oil patent while announcing management shuffle

28-Jan-2013 By Hank Schultz

Neptune Technologies and Bioressources said it will be granted a new US patent for its krill oil and has announced a management reorganization pertaining to the company’s continued efforts to recover from a fire that destroyed its manufacturing plant.

Cargill, TSI amend pact on vegan glucosamine IP

04-Dec-2012 By Hank Schultz

Cargill and TSI Group have amended an agreement on the intellectual property surrounding Cargill’s patented technology for producing vegan glucosamine.

Krill wars

Neptune and Aker facing off in court yet again

30-Nov-2012 By RJ Whitehead

Australia is the site of the latest battle between Neptune and Aker Biomarine. In addition to patent strife between the two krill majors in American courts, Canadian Neptune has now announced that it filed opposition to an Aker patent application earlier...

Aker's Australian krill composition patent survives challenge

05-Sep-2012 By Hank Schultz

Norway-based krill supplier Aker BioMarine announced Tuesday that Australian authorities have upheld the lion’s share of its Australian krill oil patent over a re-examination challenge lodged by competitor Neptune Technologies and Bioressources.

Continuation application on Neptune krill oil patent is allowed by USPTO

11-Jun-2012 By Elaine Watson

Neptune Technologies and Bioressources says the US Patent & Trademark Office (USPTO) has allowed a continuation patent application that strengthens claims in its recently-awarded US patent #8,030,348.

Natural Alternatives International secures another patent for beta-alanine

22-Mar-2012 By Elaine Watson

California-based Natural Alternatives International (NAI) has been granted a new patent covering sports nutrition ingredient beta alanine.

US Patent Office to re-examine second Neptune patent

27-Feb-2012 By Elaine Watson

The US Patent and Trademark Office (USPTO) has granted a request from Aker BioMarine to re-examine another US patent recently awarded to its arch rival Neptune Technologies & Bioressources.

Neptune ups ante in krill patent war with new ‘continuation’ applications

12-Jan-2012 By Elaine Watson

Neptune Technologies and Bioressources has filed ‘continuation’ applications with the US Patent & Trademark Office (USPTO) it says will allow it to pursue “additional patent claims that should preclude our competitors from selling their krill oil...

What can be patented in the world of natural ingredients?

09-Jan-2012 By Elaine Watson

What can be patented in the world of natural ingredients? More than you think, Minneapolis-based patent attorney Gary Speier tells Elaine Watson.

Krill oil specialist Neptune predicts 17-22% rise in Q3 revenues

02-Dec-2011 By Elaine Watson

Bosses at Canadian krill oil firm Neptune Technologies & Bioressources are confident that third quarter revenues (three months to Nov 30) will be in the $5m to $5.25m range compared with $4.29m in the same period last year, representing a 17-22% rise.

Neptune and Aker engage in public war-of-words over krill patent

17-Nov-2011 By Elaine Watson

Suggestions by Aker Biomarine that Neptune Technologies and Bioressources misrepresented the novelty of the inventions claimed in its newly-granted krill oil patent are “baseless”, Neptune bosses have insisted.

Neptune secures US patent for krill cardio health benefits

16-Nov-2011 By Elaine Watson

Neptune Technologies & Bioressources has bolstered its intellectual property portfolio further after securing a new US patent (No. 8,057,825) awarding it the exclusive use of krill extracts in the US as a method for reducing cholesterol, platelet...

Krill oil dispute turns ugly as new patent prompts wave of litigation

05-Oct-2011 By Elaine Watson

The biggest players in krill oil are at war again - this time over a US patent awarded to Neptune Technologies & Bioressources, which its arch rival argues should never have been granted, and Neptune has immediately moved to enforce in the courts.

‘Undeserved’ patents bigger issue for industry than ‘fast track’ postponement

11-May-2011 By Stephen Daniells

The indefinite postponement of the proposed Track One prioritized patent examination program will not affect the natural products industry very much, and pales in comparison to the problem of undeserved patents, says a leading industry figure.

Decas deal gives access to cranberry patents

20-Jul-2010 By Lorraine Heller

Decas Botanical Synergies (DBS) has obtained intellectual property rights covering a number of cranberry and other fruit extracts, which the firm says it will use to develop “new innovative” ingredients.

Roquette gains further maltitol patent protection in the US

04-Feb-2010 By Caroline Scott-Thomas

A US District Court has ruled that no dry form of maltitol from Yucheng Lujian Biological Co. or its associated companies may enter the US, in the latest chapter of a patent dispute filed by French firm Roquette.

Burcon files for GRAS for canola extracts

20-Jan-2010 By Shane Starling

Canadian functional protein developer, Burcon NutraScience Corporation, has taken another step to commercializing its canola protein extracts by filing for GRAS (generally recognized as safe) with the Food and Drug Administration.

Two more patents for Burcon move a step closer

16-Dec-2009 By Mike Stones

Functional renewable plant proteins company, Burcon NutraScience Corporation has received notices of allowance from the United States Patent and Trademark Office for two separate protein ingredient patent applications.

Neptune to appeal European patent revocation

15-Dec-2009 By Shane Starling

Canadian global krill leader, Neptune Bioressources and Technologies, has confirmed it will appeal a decision taken by the European Patent Office (EPO) yesterday to revoke its krill patent.

Cranberry rivals go head to head over patent case

04-Dec-2009 By Caroline Scott-Thomas

Ocean Spray claims that a federal judge has ruled to allow an independent inspector to check whether rival cranberry company Decas has infringed its patents for producing sweetened dried cranberries (SDC).